TABLE 2.
PIa | No. (%) of patients with prior use |
---|---|
ATV | 8 (15) |
IDV | 45 (83) |
SQV | 44 (81) |
NFV | 33 (61) |
LPV | 38 (70) |
APV | 43 (80) |
TPV | 20 (37) |
ATV, atazanavir; IDV, indinavir; SQV, saquinavir; NFV, nelfinavir; LPV, lopinavir; APV, amprenavir; TPV, tipranavir.